Trials / Completed
CompletedNCT01011504
Utilisation of Angiox® in European Practice
A Registry Study to Determine Utilisation Patterns in Patients Receiving Angiox®, and Collect Descriptive Safety and Outcome Data to Inform the Risk Management Strategy for Europe.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,019 (actual)
- Sponsor
- The Medicines Company · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine utilisation patterns in patients receiving Angiox® in participating European centres. Additionally, through the collection of descriptive safety and outcomes data, this study will contribute to the Risk Management strategy for Europe
Conditions
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-10-01
- Completion
- 2010-12-01
- First posted
- 2009-11-11
- Last updated
- 2012-01-19
Locations
2 sites across 2 countries: France, Germany
Source: ClinicalTrials.gov record NCT01011504. Inclusion in this directory is not an endorsement.